It is especially difficult in cancer patients, due to the many factors related to the underlying malignancy (e.g. stage, type, hormone receptor status), and the estimation whether the patient will be able to receive future anti-cancer treatment after ICU admission [1,36]. Here, NR4A1 is linked to cancer.